Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully May 28, 2025 23:29 HKT/SGT Read More
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China May 28, 2025 16:45 HKT/SGT Read More
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 May 21, 2025 14:00 HKT/SGT Read More
Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro May 16, 2025 16:21 HKT/SGT Read More
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited May 14, 2025 15:00 HKT/SGT Read More
Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China May 07, 2025 18:06 HKT/SGT Read More
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards May 05, 2025 19:30 HKT/SGT Read More
Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star Apr 30, 2025 13:17 HKT/SGT Read More
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia Apr 25, 2025 15:49 HKT/SGT Read More
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025 Apr 24, 2025 18:43 HKT/SGT Read More
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union Apr 18, 2025 15:52 HKT/SGT Read More
analytica Vietnam 2025 Concludes with Record-Breaking Attendance and Exhibitor Participation Apr 16, 2025 23:55 HKT/SGT Read More
エーザイとバイオジェン、「レケンビ」(レカネマブ)が欧州連合(EU)において早期アルツハイマー病の進行を抑制する初めての治療剤として承認を取得 Apr 16, 2025 11:30 JST Read More